Review



myd88 homodimerization inhibitor peptide  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Novus Biologicals myd88 homodimerization inhibitor peptide
    The effect of MPLA mediated inflammatory preconditioning (InP) on cav-1 -/- mice. (A) Survival curves, n=8 mice per group. The mice were first given 0.1×10 8 CFUs E. coli , followed by the lethal dose of E. coli (3×10 8 CFUs) 2 h later,* vs. Saline. (B) Experimental procedures. (1) The WT mice were injected i.p. with 0.1×10 8 CFUs E. coli, and 2 h later were injected with 3×10 8 CFUs E. coli per mouse, and all 8 mice survived (InP). (2) C av-1 -/ - mice were injected i.p. with 0.1×10 8 E. coli, and 2 h later were injected with 3×10 8 CFUs E. coli, and all 8 mice died. (C) Intestine and liver tissues of mice stained with H&E. (D) ELISA of TNF-α/IL-6 in the supernatants of peripheral blood neutrophils in mice stimulated with 0.1×10 8 CFUs E. coli for 2 h. ** P <0.01 (Student's t test). (E) Western blot shows that InP did not promote translocation of TLR9 from cytosol to cell membrane in cav -/- mice. (F) Western blot shows significant reduction of endogenous Cav-1 by shRNA against Cav-1 (Cav-1 shRNA). (G) Immunoblot of TLR9, <t>MyD88,</t> TRAF3 and IRF3 in HL60 cells transfected Cav-1 shRNA and then stimulated with 0.1×10 8 CFUs E. coli for indicated times. Similar results were obtained in three independent experiments. (H) ELISA of TNF-α/IL-6 in the supernatants of HL60 cells transfected Cav-1 shRNA, stimulated with 0.1×10 8 CFUs E. coli for 2 h. ** P <0.01 (Student's t test).
    Myd88 Homodimerization Inhibitor Peptide, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 103 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/MyD88+Inhibitor+Peptide+Set/pmc06735515-173-0-8
    Average 94 stars, based on 103 article reviews
    myd88 homodimerization inhibitor peptide - by Bioz Stars, 2026-11
    94/100 stars

    Images

    1) Product Images from "Membrane TLR9 Positive Neutrophil Mediated MPLA Protects Against Fatal Bacterial Sepsis"

    Article Title: Membrane TLR9 Positive Neutrophil Mediated MPLA Protects Against Fatal Bacterial Sepsis

    Journal: Theranostics

    doi: 10.7150/thno.37139

    The effect of MPLA mediated inflammatory preconditioning (InP) on cav-1 -/- mice. (A) Survival curves, n=8 mice per group. The mice were first given 0.1×10 8 CFUs E. coli , followed by the lethal dose of E. coli (3×10 8 CFUs) 2 h later,* vs. Saline. (B) Experimental procedures. (1) The WT mice were injected i.p. with 0.1×10 8 CFUs E. coli, and 2 h later were injected with 3×10 8 CFUs E. coli per mouse, and all 8 mice survived (InP). (2) C av-1 -/ - mice were injected i.p. with 0.1×10 8 E. coli, and 2 h later were injected with 3×10 8 CFUs E. coli, and all 8 mice died. (C) Intestine and liver tissues of mice stained with H&E. (D) ELISA of TNF-α/IL-6 in the supernatants of peripheral blood neutrophils in mice stimulated with 0.1×10 8 CFUs E. coli for 2 h. ** P <0.01 (Student's t test). (E) Western blot shows that InP did not promote translocation of TLR9 from cytosol to cell membrane in cav -/- mice. (F) Western blot shows significant reduction of endogenous Cav-1 by shRNA against Cav-1 (Cav-1 shRNA). (G) Immunoblot of TLR9, MyD88, TRAF3 and IRF3 in HL60 cells transfected Cav-1 shRNA and then stimulated with 0.1×10 8 CFUs E. coli for indicated times. Similar results were obtained in three independent experiments. (H) ELISA of TNF-α/IL-6 in the supernatants of HL60 cells transfected Cav-1 shRNA, stimulated with 0.1×10 8 CFUs E. coli for 2 h. ** P <0.01 (Student's t test).
    Figure Legend Snippet: The effect of MPLA mediated inflammatory preconditioning (InP) on cav-1 -/- mice. (A) Survival curves, n=8 mice per group. The mice were first given 0.1×10 8 CFUs E. coli , followed by the lethal dose of E. coli (3×10 8 CFUs) 2 h later,* vs. Saline. (B) Experimental procedures. (1) The WT mice were injected i.p. with 0.1×10 8 CFUs E. coli, and 2 h later were injected with 3×10 8 CFUs E. coli per mouse, and all 8 mice survived (InP). (2) C av-1 -/ - mice were injected i.p. with 0.1×10 8 E. coli, and 2 h later were injected with 3×10 8 CFUs E. coli, and all 8 mice died. (C) Intestine and liver tissues of mice stained with H&E. (D) ELISA of TNF-α/IL-6 in the supernatants of peripheral blood neutrophils in mice stimulated with 0.1×10 8 CFUs E. coli for 2 h. ** P <0.01 (Student's t test). (E) Western blot shows that InP did not promote translocation of TLR9 from cytosol to cell membrane in cav -/- mice. (F) Western blot shows significant reduction of endogenous Cav-1 by shRNA against Cav-1 (Cav-1 shRNA). (G) Immunoblot of TLR9, MyD88, TRAF3 and IRF3 in HL60 cells transfected Cav-1 shRNA and then stimulated with 0.1×10 8 CFUs E. coli for indicated times. Similar results were obtained in three independent experiments. (H) ELISA of TNF-α/IL-6 in the supernatants of HL60 cells transfected Cav-1 shRNA, stimulated with 0.1×10 8 CFUs E. coli for 2 h. ** P <0.01 (Student's t test).

    Techniques Used: Saline, Injection, Staining, Enzyme-linked Immunosorbent Assay, Western Blot, Translocation Assay, Membrane, shRNA, Transfection

    Expression of TLR9-Cav-1 signaling proteins in the neutrophils of patients with sepsis. (A) Membrane TLR9 expression. (B) Cav-1 expression. (C) ROC curve for mTLR9. P <0.05. (D) ROC curve for Cav-1. P <0.05. (E) Association of Cav-1 with surface TLR9 expression in neutrophils. r2 =0.5791. (F) MyD88 expression. (G) TRAF3 expression. (H) IRF3 expression.
    Figure Legend Snippet: Expression of TLR9-Cav-1 signaling proteins in the neutrophils of patients with sepsis. (A) Membrane TLR9 expression. (B) Cav-1 expression. (C) ROC curve for mTLR9. P <0.05. (D) ROC curve for Cav-1. P <0.05. (E) Association of Cav-1 with surface TLR9 expression in neutrophils. r2 =0.5791. (F) MyD88 expression. (G) TRAF3 expression. (H) IRF3 expression.

    Techniques Used: Expressing, Membrane

    Related Articles

    Inhibition:

    Article Title: Characterization of the Inflammatory Response Evoked by Bacterial Membrane Vesicles in Intestinal Cells Reveals an RIPK2-Dependent Activation by Enterotoxigenic Escherichia coli Vesicles.
    Article Snippet: .. For inhibition assays, HT-29 cells (6 105 cells/well) were treated for 3 h with or without inhibitor for NOD1 (ML130; 10 mM) (Sigma-Aldrich), NOD2 (GSK717; 10 mM) (Sigma-Aldrich), MyD88 (NBP2-29328; 10 mM) (Novus Biological), tyrosine kinases (gefitinib; 10 mM), caspase-1,4,5 (Z-YVAD-FMK; 10 mM) (SigmaAldrich), and Rip2 kinase (GSK583; 5 mM) (Sigma-Aldrich) in DMEM–F-12 medium supplemented with glutamate and penicillin G, but without fetal bovine serum, before MVs (100 ng/mL protein equivalent) were added. ..

    Activity Assay:

    Article Title: SARS-CoV-2 activates the TLR4/MyD88 pathway in human macrophages: A possible correlation with strong pro-inflammatory responses in severe COVID-19
    Article Snippet: In order to selectively block TLR4 signalling in cells, the inhibitor TAK-242 (Merck, 614316) was used at 10 μM [ ]. .. The angiotensin converting enzyme 2 (ACE2) activity inhibitor MLN-4760 (Merck, 530616) was employed at 10 μM [ ], the TLR3 inhibitor (R)-2-(3-Chloro-6-fluorobenzo[b]thiophene-2-carboxamido)-3-phenylpropanoic acid (Merck, 614310) at 30 μM [ ], the TIR-domain-containing adapter-inducing interferon-β (TRIF) inhibitor peptide (pepinh-TRIF, InvivoGen, tlrl-pitrif) at 5 μM (manufacturer's instruction), the Myeloid differentiation primary response 88 (MyD88) inhibitor peptide NBP2-29328 (Novus Biologicals, NBP2-29328) at 10 μM, the TNF receptor associated factor 6 (TRAF6) inhibitor C25-140 (MedChem Express, HY-120934) at 30 μM [ ], the TMPRSS2 inhibitor Camostat mesylate (TOCRIS, 3193) at 10 μM [ ], the Cathepsin B and L inhibitor E−64d (TOCRIS, 4545) at 10 μM [ ], the spike binding protein (SBP1, TOCRIS, 7233) at 10 μM (manufacturer's instruction), the TLR7/9 inhibitor hydroxychloroquine sulfate (MedChem Express, HY-B1370) at 12 μM [ ]. .. Lipopolysaccharide (LPS, 10 ng/ml, Sigma, L2630) and Poly I:C (20 μg/ml, TOCRIS, 4287) served as a positive control for TLR4-and TLR3-dependent inflammation.

    Binding Assay:

    Article Title: SARS-CoV-2 activates the TLR4/MyD88 pathway in human macrophages: A possible correlation with strong pro-inflammatory responses in severe COVID-19
    Article Snippet: In order to selectively block TLR4 signalling in cells, the inhibitor TAK-242 (Merck, 614316) was used at 10 μM [ ]. .. The angiotensin converting enzyme 2 (ACE2) activity inhibitor MLN-4760 (Merck, 530616) was employed at 10 μM [ ], the TLR3 inhibitor (R)-2-(3-Chloro-6-fluorobenzo[b]thiophene-2-carboxamido)-3-phenylpropanoic acid (Merck, 614310) at 30 μM [ ], the TIR-domain-containing adapter-inducing interferon-β (TRIF) inhibitor peptide (pepinh-TRIF, InvivoGen, tlrl-pitrif) at 5 μM (manufacturer's instruction), the Myeloid differentiation primary response 88 (MyD88) inhibitor peptide NBP2-29328 (Novus Biologicals, NBP2-29328) at 10 μM, the TNF receptor associated factor 6 (TRAF6) inhibitor C25-140 (MedChem Express, HY-120934) at 30 μM [ ], the TMPRSS2 inhibitor Camostat mesylate (TOCRIS, 3193) at 10 μM [ ], the Cathepsin B and L inhibitor E−64d (TOCRIS, 4545) at 10 μM [ ], the spike binding protein (SBP1, TOCRIS, 7233) at 10 μM (manufacturer's instruction), the TLR7/9 inhibitor hydroxychloroquine sulfate (MedChem Express, HY-B1370) at 12 μM [ ]. .. Lipopolysaccharide (LPS, 10 ng/ml, Sigma, L2630) and Poly I:C (20 μg/ml, TOCRIS, 4287) served as a positive control for TLR4-and TLR3-dependent inflammation.



    Similar Products

    95
    Zymo Research dnase i
    Dnase I, supplied by Zymo Research, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/DNase+I+Set+w%2F+DNA+Digestion+Buffer/pmc13759040-139-4-7
    Average 95 stars, based on 1 article reviews
    dnase i - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    98
    Complete Genomics Inc dnbseq t7rs platform
    Dnbseq T7rs Platform, supplied by Complete Genomics Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/FCL+PE100+Sequencing+Set+V1%2E0/pm42956743-1026-7--1
    Average 98 stars, based on 1 article reviews
    dnbseq t7rs platform - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    90
    Occlutech GmbH delivery set (ods
    Delivery Set (Ods, supplied by Occlutech GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/delivery+set++ods/nct05264753-0-29-29
    Average 90 stars, based on 1 article reviews
    delivery set (ods - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    96
    Illumina Inc truseq small rna sample prep kit
    Truseq Small Rna Sample Prep Kit, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/TruSeq+Small+RNA+Library+Prep+Kit+-Set+A/pm42998579-66-8-14
    Average 96 stars, based on 1 article reviews
    truseq small rna sample prep kit - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    98
    Complete Genomics Inc mgieasy universal dna library prep set
    Mgieasy Universal Dna Library Prep Set, supplied by Complete Genomics Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/MGIEasy+Universal+DNA+Library+Prep+Set%2C+96+RNX/pmc13752511-56-0-9
    Average 98 stars, based on 1 article reviews
    mgieasy universal dna library prep set - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    94
    Sino Biological mouse il 6 elisa kit
    NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, <t>Il‐6,</t> Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Mouse Il 6 Elisa Kit, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/Mouse+IL6ST+%2F+gp130+%2F+CD130+ELISA+Pair+Set/pmc13752232-299-7-14
    Average 94 stars, based on 1 article reviews
    mouse il 6 elisa kit - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    Carl Zeiss filter set 92 he led
    NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, <t>Il‐6,</t> Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Filter Set 92 He Led, supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/Filter+set+92+HE+LED+(E)/pm42790276-76-25-30
    Average 96 stars, based on 1 article reviews
    filter set 92 he led - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    98
    Complete Genomics Inc mgieasy rna library prep set
    NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, <t>Il‐6,</t> Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Mgieasy Rna Library Prep Set, supplied by Complete Genomics Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/MGIEasy+Fast+RNA+Library+Prep+Set/pmc13764288-329-6-22
    Average 98 stars, based on 1 article reviews
    mgieasy rna library prep set - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    96
    World Precision Instruments stx 2 electrodes
    NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, <t>Il‐6,</t> Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Stx 2 Electrodes, supplied by World Precision Instruments, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/Chopstick+Electrode+Set+for+EVOM2%2C+-+DISCONTINUED/pm42988245-50-24-27
    Average 96 stars, based on 1 article reviews
    stx 2 electrodes - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Illumina Inc truseq small rna library preparation kits
    NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, <t>Il‐6,</t> Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Truseq Small Rna Library Preparation Kits, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/set/TruSeq+Small+RNA+Library+Prep+Kit+-Set+A/pm42992648-129-14-29
    Average 96 stars, based on 1 article reviews
    truseq small rna library preparation kits - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, Il‐6, Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Journal: Exploration

    Article Title: Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation

    doi: 10.1002/exp2.70249

    Figure Lengend Snippet: NANP alters the immunomodulatory properties of MSCs‐exo. (A) Strategy for in vitro MSCs‐exo‐mediated inhibition of OT‐I cell proliferation. (B) Representative histograms showing the proliferation of eFluor670‐labeled OT‐I cells in vitro. Statistical analysis of OT‐I cell‐associated MFI is shown ( n = 3). (C, D) Representative histograms illustrating CD86 (C) and MHC‐II (D) expression in BMDC after Poly(I:C) stimulation with or without different MSCs‐exo. Statistical analysis of mean fluorescence intensity (MFI) is shown ( n = 3). (E, F) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, and then cultured with 20 µg mL −1 exosomes from MSCs or NAD + ‐loaded MSCs for another 12 h. The mRNA expressions of Tnf‐a, Il‐6, Nos2 , and Il‐10 genes were detected by using qRT‐PCR assay (E) ( n = 3), and the proportions of iNOS + F4/80 + and CD206 + F4/80 + cells were detected by flow cytometry (F) (n = 3). (G) Relative Pd‐l1 mRNA levels in MSCs treated with IT, 25 µM NANP, or a combination of both for 24 h (bottom panel), and Western blot analysis of PD‐L1 in exosomes derived from MSCs treated with 25 µM NANP or not (top panel). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Article Snippet: Serum IL‐6 levels were measured using a mouse IL‐6 ELISA kit ( SEK50135 , Sino Biological Inc.).

    Techniques: In Vitro, Inhibition, Labeling, Analysis, Expressing, Fluorescence, Cell Culture, Exosomes, Quantitative RT-PCR, Flow Cytometry, Western Blot, Derivative Assay

    NANP modulates the miRNA content in exosomes through the upregulation of SMPD3. (A) Volcano plot showing the differential expression analysis of miRNAs between MSCs‐exo and NAD + ‐loaded MSCs‐exo. (B) GO analysis of significantly enriched genes in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (C) Heatmap illustrating the upregulation of miRNAs in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (D) qRT‐PCR analysis of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p expression in exosomes from MSCs treated with or without NANP. (E) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, followed by transfection with siRNA‐ctrl or a combination of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p mimics (miR‐30a/146a/146b) for an additional 24 h. The mRNA expressions of the Tnf‐a , Il‐6 , Nos2 , and Il‐10 genes were detected using qRT‐PCR ( n = 3). (F) The mRNA expressions of Hnrnpa2b1 , Smpd3 , Anxa2 , Ybx1 , and Syncrip of MSCs with or without 25 µM NANP treatment for 48 h ( n = 3). (G) Protein levels of SMPD3 and YBX1 in MSCs with or without NANP (25 µM, 48 h) treatment. (H) Western blot and qRT‐PCR showing that MSCs with shRNA‐mediated SMPD3 knockdown (MSCs‐sh‐Smpd3) fail to respond to NANP‐induced SMPD3 upregulation. (I) Western blot analysis of the exosomal markers TSG101 and CD81 detected in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 cells. (J) The expression of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 in the presence or absence of NANP, measured by qRT‐PCR ( n = 3). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Journal: Exploration

    Article Title: Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation

    doi: 10.1002/exp2.70249

    Figure Lengend Snippet: NANP modulates the miRNA content in exosomes through the upregulation of SMPD3. (A) Volcano plot showing the differential expression analysis of miRNAs between MSCs‐exo and NAD + ‐loaded MSCs‐exo. (B) GO analysis of significantly enriched genes in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (C) Heatmap illustrating the upregulation of miRNAs in NAD + ‐loaded MSCs‐exo compared to MSCs‐exo. (D) qRT‐PCR analysis of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p expression in exosomes from MSCs treated with or without NANP. (E) RAW264.7 cells were pretreated with LPS (100 ng mL −1 ) and IFN‐γ (10 ng mL −1 ) for 2 h, followed by transfection with siRNA‐ctrl or a combination of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p mimics (miR‐30a/146a/146b) for an additional 24 h. The mRNA expressions of the Tnf‐a , Il‐6 , Nos2 , and Il‐10 genes were detected using qRT‐PCR ( n = 3). (F) The mRNA expressions of Hnrnpa2b1 , Smpd3 , Anxa2 , Ybx1 , and Syncrip of MSCs with or without 25 µM NANP treatment for 48 h ( n = 3). (G) Protein levels of SMPD3 and YBX1 in MSCs with or without NANP (25 µM, 48 h) treatment. (H) Western blot and qRT‐PCR showing that MSCs with shRNA‐mediated SMPD3 knockdown (MSCs‐sh‐Smpd3) fail to respond to NANP‐induced SMPD3 upregulation. (I) Western blot analysis of the exosomal markers TSG101 and CD81 detected in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 cells. (J) The expression of miR‐30a‐5p, miR‐146a‐5p, and miR‐146b‐5p in exosomes derived from MSCs‐sh‐Ctrl and MSCs‐sh‐Smpd3 in the presence or absence of NANP, measured by qRT‐PCR ( n = 3). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Article Snippet: Serum IL‐6 levels were measured using a mouse IL‐6 ELISA kit ( SEK50135 , Sino Biological Inc.).

    Techniques: Exosomes, Quantitative Proteomics, Analysis, Quantitative RT-PCR, Expressing, Transfection, Western Blot, shRNA, Knockdown, Derivative Assay, Cell Surface Receptor Assay, Gene Expression